Jacks Lee - 27 Jun 2022 Form 3 Insider Report for G1 Therapeutics, Inc.

Role: Director
Signature: /s/ James Stillman Hanson, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 27 Jun 2022
Net transactions value: $0
Form type: 3
Filing time: 29 Jun 2022, 17:54:26 UTC
Next filing: 16 Jun 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

24.1 - Power of Attorney